IT: The application of information technology in process development and pharmaceutical manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

IT
Mobile technology, wireless monitoring systems, RFID. LIMS and electronic notebook systems. Automation, QBAS, & process analytical technology. Service-oriented architecture & integration. Risk management and CAPA.

Week of Dec. 27, 2010: Company and People Notes: AstraZeneca and Abbott End Program; PhRMA Elects New Members; and More.

December 30, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

AstraZeneca and Abbott End Program; PhRMA Elects New Members; and More.

Week of Dec. 20, 2010: Company and People Notes: Pfizer Recalls One Lipitor Lot; Sanofi Aventis Names Head of R&D; and More.

December 23, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Recalls One Lipitor Lot; Sanofi Aventis Names Head of R&D; and More.

Week of Dec. 13, 2010: Company and People Notes: Thermo Fisher to Acquire Dionex; Former SOCMA CEO Joe Acker Dies; and More.

December 16, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Thermo Fisher to Acquire Dionex; Former SOCMA CEO Joe Acker Dies; and More.

December 2010 Editor's Picks: Products from Fitzpatrick and Parsec Automation

December 15, 2010
Equipment and Processing Report

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the November 2010 edition from Fitzpatrick and Parsec Automation.

Week of Dec. 6, 2010: Company and People Notes: GlaxoSmithKline Acquires Nanjing MeiRui Pharma; Cephalon's CEO to Remain on Medical Leave; and More.

December 9, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: GlaxoSmithKline acquires Nanjing MeiRui Pharma; Cephalon's CEO to remain on medical leave; and more.

Quality Issues Redux

December 2, 2010

Pharmaceutical Technology

As we get ready to begin the New Year, let's hope some quality resolutions are made.

Week of Nov. 29, 2010: Company and People Notes: Lonza Forms Agreements with Two Partners; Covance Makes Executive Appointments; and More.

December 2, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Lonza Forms Agreements with Two Partners; Covance Makes Executive Appointments; and More.

Week of Nov. 22, 2010: Company and People Notes: Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

November 24, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

Week of Nov. 15, 2010: Company and People Notes: Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

November 18, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here